For the quarter ending 2025-08-31, CCEL has $63,169,129 in assets. $78,000,528 in debts. $265,207 in cash and cash equivalents.
| Balance Sheets | 2025-08-31 | 2025-05-31 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 265,207 | 137,491 | ||
| Marketable securities | 2,956,238 | 4,293,513 | ||
| Accounts receivable (net of allowance for doubtful accounts of 4,416,201 and 4,266,406, respectively) | 6,833,380 | 6,931,474 | ||
| Prepaid expenses | 617,930 | 621,345 | ||
| Inventory, current portion | 655,254 | 676,764 | ||
| Other current assets | 344,994 | 392,333 | ||
| Total current assets | 11,673,003 | 13,052,920 | ||
| Property and equipment-net | 21,199,002 | 21,391,845 | ||
| Intangible assets, net | 874,229 | 887,321 | ||
| Inventory, net of current portion | 4,864,834 | 4,864,835 | ||
| Goodwill | 1,941,411 | 1,941,411 | ||
| Deferred tax assets | 20,802,023 | 20,802,023 | ||
| Operating lease right-of-use asset | 906,848 | 620,225 | ||
| Deposits and other assets, net | 907,779 | 877,329 | ||
| Total other assets | 30,297,124 | 29,993,144 | ||
| Total assets | 63,169,129 | 64,437,909 | ||
| Accounts payable | 2,611,921 | 2,241,446 | ||
| Accrued expenses | 2,284,575 | 2,673,698 | ||
| Note payable | 179,187 | 177,603 | ||
| Line of credit | 3,200,000 | 6,620,000 | ||
| Current portion of operating lease liability | 434,604 | 465,231 | ||
| Deferred revenue | 9,741,319 | 9,574,621 | ||
| Total current liabilities | 18,451,606 | 21,752,599 | ||
| Deferred revenue, net of current portion | 49,842,932 | 48,818,976 | ||
| Note payable, net of current portion and debt issuance costs | 8,206,768 | 8,238,979 | ||
| Operating lease long-term liability | 577,202 | 265,140 | ||
| Long-term liability - revenue sharing agreements | 875,000 | 875,000 | ||
| Other liabilities | 47,020 | 47,020 | ||
| Total other liabilities | 59,548,922 | 58,245,115 | ||
| Total liabilities | 78,000,528 | 79,997,714 | ||
| Preferred stock | 0 | 0 | ||
| Preferred stock-Series APreferred Stock | 0 | 0 | ||
| Common stock (.01 par value, 20,000,000 authorized 14,877,119 issued and 8,055,150 outstanding as of august 31, 2025 and 14,869,619 issued and 8,082,159 outstanding as of november 30, 2024) | 148,771 | 148,696 | ||
| Additional paid-in capital | 44,665,693 | 44,605,887 | ||
| Treasury stock, at cost | 25,025,058 | 24,944,175 | ||
| Accumulated deficit | -34,620,805 | -35,370,213 | ||
| Total stockholders' deficit | -14,831,399 | -15,559,805 | ||
| Total liabilities and stockholders' deficit | 63,169,129 | 64,437,909 | ||
CRYO CELL INTERNATIONAL INC (CCEL)
CRYO CELL INTERNATIONAL INC (CCEL)